chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lymph node swelling noticed in the left clavicle area/swollen lymph node around her left clavicle; Lymph node swelling noticed in the left clavicle area/Did hurt at the beginning; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 18Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 03Jan2021, the patient experienced lymph node swelling noticed in the left clavicle area. No pain now but did hurt at the beginning "for a few days." The patient stated her doctor did an ultrasound of both sides of chest and both clavicle areas: unknown result. The patient was asking if this has been reported in other patients. The patient stated, "I have read everything on lymph edema, I want some specific information regarding the swollen lymph node around my left clavicle. I am really concerned because nobody can tell me anything. I am a nurse and if this is normal side effect from the vaccine then tell me or do I need to get a biopsy for lymphoma?". The outcome of the events was recovered in Jan2021.  Information on the Batch/Lot number has been requested.
Pt presents today at Minuteclinic stated that he got a small pimple on his right hand 2 days after the second shot pfizer monovalent. He received the vaccine at Pharmacy.  The pimple was very itchy at that time, and then started to become rash on right hand. The rash is getting progressively worse, which covers his back, chest and most all extremities. He denies having this rash before and claims to be healthy otherwise. He took OTC cream and benadryl for the past 2 weeks but with minimal relief. Denies SOB, fever, or angioedema.
Fever days after booster dose; Patient felt nauseated; Felt achy days after booster dose; Patient received first dose of Moderna on 28/Jan/2021 and second dose on 25/Jun/2021; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Felt achy days after booster dose), PYREXIA (Fever days after booster dose), NAUSEA (Patient felt nauseated) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose of Moderna on 28/Jan/2021 and second dose on 25/Jun/2021) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939906, 002A21A and 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS, Cough and Sinus disorder (Sinus issue).   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose of Moderna on 28/Jan/2021 and second dose on 25/Jun/2021). On 08-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (Felt achy days after booster dose). On 09-Nov-2021, the patient experienced NAUSEA (Patient felt nauseated). On 10-Nov-2021, the patient experienced PYREXIA (Fever days after booster dose). On 25-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose of Moderna on 28/Jan/2021 and second dose on 25/Jun/2021) had resolved. At the time of the report, MYALGIA (Felt achy days after booster dose), PYREXIA (Fever days after booster dose) and NAUSEA (Patient felt nauseated) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, SARS-CoV-2 test: negative (Negative) Negative.         No Concomitant medications were reported. No Treatment information was reported.
Systemic: Exhaustion / Lethargy-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild
got the first dose of the Moderna vaccine on 01Apr2021 and has not got the second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 01Apr2021 and has not got the second dose yet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 01Apr2021 and has not got the second dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 01Apr2021 and has not got the second dose yet) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  treatment medications was not given.
Soft lump in right forearm; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (COMIRNATY; Lot Number: EN6208) via an unspecified route of administration in the right arm on 15Mar2021 at 09:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had unspecified allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 15Mar2021 at 10:00, the patient experienced soft lump in right forearm. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soft lump in right forearm was not resolved at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Symptoms: High levels of pain in the arm that received the vaccination, runny nose, stuffy nose, headache the morning following the vaccination, high fever (102-103) the night of the vaccination, and nausea the day after the vaccination.
Pt had immunizations at her office visit. Started to have chills, nausea and her L arm was warm to touch. Arm became more red, pain at injection site, swollen area at injection site. Pt remembers nurse telling her the L arm was the Hep B vaccine, however documented in chart as Prevnar 20 in L arm
On November 29, 2011 patient called in to report a diagnosis of Guillain-Barre Syndrome. Patient stated that he received the flu shot on the end of September and a few days to one week after he started noticing symptoms. His legs were "wobbly", pain in his back, and tingling in his hands. Days went on and the symptoms were getting worse. His legs "went out" and his hands were in severe pain. He went to a local hospital, kept him there for three days but told him there is nothing they can do for him. That hospital sent him to another Hospital to see a neurologist.  The doctor performed a nerve conduction test and a spinal test, which they diagnosed patient with GBS.  He spent a combined total of 15 days in the hospital; he was released on November 23, 2011. He is still experiencing pain in his extremities, his equilibrium is off, must use a walker to be able to get around, and only has 75%-90% use in his hands. They told him the symptoms can last anywhere from 6 months to 2 years or longer. He stated that his body just doesn't work.
Patient had flare of her Tolosa Hunt Syndrome. She had nerve pain on the left side of face since yesterday. Aggravated with double vision
VACCINE EXPOSURE DURING PREGNANCY; This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 40-year-old female subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis during pregnancy.   The subject's medical history included two previous normal full-term live births. Concurrent medical conditions included anemia and depression.   Concurrent medications included Sertraline hydrochloride (Zoloft).   On 1 September 2011 the subject received a dose of Boostrix (.5 unknown units, intramuscular, unknown site), and experienced vaccine exposure during pregnancy.  The subejct was approximately 25 weeks gestation at the time of vaccination.  Date of last menstrual period was 15 March 2011 and estimated delivery date was 09 December 2011.  The subject had not been using contraception prior to becoming pregnant and the conception was reported to be normal.  Prenatal testing, including ultrasound and amniocentesis on 21 July 2011 revealed no evidence of a defect.   Upon internal review done on 16th September 2019, the pregnancy outcome was updated to lost to follow-up.      Lab Comments: Lab Tests: Ultrasound and amniocentesis on 21 July 2011 revealed no evidence of a defect.
c/o fever & swelling in lt arm the next day;states fever cont till yesterday w/some remaining today;no erythema, note edema anterior aspect of inc arm w/hard knot beneath site of inj;
Began with shortness of breath and an overwhelming feeling of un-wellness.  Went to Urgent Care and had tachycardia; sent to the ER then admitted to the hospital for 8 days.   AFib with RVR Nonischemic Cardiomyopathy EF= 25-30 Fluid in lungs  Currently on 7 prescription medications and care is managed by on-going treatment by cardiologist.
Tested positive for covid last weekend; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid last weekend) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046a21a) for COVID-19 vaccination.     The patient's past medical history included COVID-19 virus test positive. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid last weekend). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid last weekend) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were reported by the reporter. Patient received first Moderna vaccine on 3-3-2021. Patient received second Moderna vaccine on 4-1-2021.
Pt noted by mother to have seizure activity, difficulty breathing.  Did not seek care for this as pt recovered spontaneously.  Developed exaggerated local response the next day and went to ED.
Severe headaches - Drank lots of water and took Ibuprofen. Headaches remained for 4-5 days. Sore joints. - Whole body ached and joints for sore for 2 days following 1st dose. Sore arm at site of injection. - Sore arm lasted for about 3 days.
Pt. stated that she received the vaccine on March 19th, 2021 and a few hours later experienced chills, fatigue and a sore arm. The patient states she later started to feel numbness in her arm which has progressively worsened over the past few days and traveled down the left side of her body to her leg.
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (minor arm pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 030L20A) for COVID-19 immunization. No medical history information reported. On Jan 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 22, 2021, patient experienced pain in extremity (minor arm pain). At the time of the report, pain in extremity (minor arm pain) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information reported.
hypersensitivity in body/arms/legs, tingling/numbness L arm started a few hours after the 2nd shot and lasted 3 weeks. Within 2 days of the 2nd shot episodic electric shock feeling to my tongue. this lasted 4 weeks. I sought medical care through my pcp's office.
pt recvd vax;noticed couple of blood spots on middle of tongue & lot of tiny blood spots all over legs & bruises on body;ped dx poss ITP;platelet count very low;down to 11,000;was hospitalized same afternoon 2pm; given imuno globulin 3x;
Cervical and supraclavicular lymphadenopathy on the same side as injection. Worsened after second vaccine dose
2 hours post influenza vaccine, redness and swelling, much discomfort - missing school today d/t the pain.
Developed fever, body aches, extreme fatigue within 12 hours of vaccine which persisted for 72 hours. Then developed left elbow pain 1 week following vaccination and olecranon bursitis 11 days following vaccination.
Patient admitted to hospital on 04/20/2021 for significant shortness of breath; patent tested positive for COVID-19 despite being fully vaccinated against it. Patient died on 04/24/2021.   Death Certificate Information:  Part I: Cause of Death: A. Repiratory Arrest B. COVID-19  Part II Other Significant Conditions COPD; Multiple Myeloma
pt recv vax JUN95 & in FEB96 pt exp shingles-like lesions over rt eye;presented to ER & tx w/med;
Information has been received from a physician concerning a female patient who was vaccinated with a first 0.5 ml dose of Gardasil. Two days later, the patient developed a full body rash. The patient's full body rash persisted. Unspecified medical attention was sought. At the time of this report, the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
significant repository issues; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RESPIRATORY DISORDER (non-serious), outcome "unknown", described as "significant repository issues". Additional information: The reporter called regarding assistance with the ABRYSVO vaccine. During the call, the reporter stated that the primary care was very anxious about the patient getting a RSV shot and that was because the patient have been diagnosed with significant repository issues, the patient gotten COVID shot, "and by the way got your COVID shot".   The information on the batch/lot number for BNT162B2 has been requested and will be submitted if and when received.
Information has been received from a nurse referring to multiple unspecified patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates these patients were vaccinated with unspecified number of doses of improperly stored ROTATEQ (lot# K016261, expiration date 23-JUN-2016; lot# K016311, expiration date 26-MAY-2016; lot# reported as K016260, expiration date 05-MAY-2016; dose not reported) orally. No adverse event was reported. This is one of two reports received from the same reporter. Additional information has been requested.
I did not have a reaction to the COVID-19 vaccine. I ended up getting COVID-19. When I reported it, they said that's an adverse reaction.
Persistent headache, more painful than other headaches I've experience (which are not that many). I could feel it as soon as I woke up, and I feel it still (~6:00 PM). It's always there, but the pain is augmented when I am moving around or walking.
Liver failure. Septic. Legs Swollen, couldn't walk. Was given Shingles and possibly flu vaccine.
Erythematous discoloration of the site of vaccine and surrounded area with associated tenderness and induration-size increased 8 cm x 6 1/2 cm (Increased temperature locally).
large lump on the the arm where the vaccine was administered(smaller than a tennis ball size)hard and painful.  pt to consider calling provider and using Ibuprophen resolution unknown
On 01/03/2023, I had pain when swallowing, felt like I had the flu, difficulty breathing. I called the doctor. Our friend who spent New Year's with us was positive. I took over the counter medicines. I was really ill for two weeks and still have trouble with shortness of breath. I have been referred for pulmonary rehab.
shingles/ Between Saturday and Sunday I came up with I guess a small amount of the doctor said maybe shingles; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 70-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 11Jan2021 as a first dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient was asking if he can take the second shot after getting shingles from 06Feb2021. He got the first dose last 11Jan2021 and supposedly to take the second one tomorrow (11Feb2021). Patient asked if the COVID-19 vaccine was the reason behind his shingles. Between Saturday and Sunday, 06Feb2021 and 07Feb2021, patient came up with what he guessed was a small amount of the doctor said maybe shingles. It was then reported that patient was scheduled/supposed to get second Pfizer-Biontech Covid-19 vaccine at the time of the report (11Feb2021) at 10am.  He planned to contact his physician, before his appointment, so was not transferred to Safety. Patient was being alright, he was just seeing those on his shoulder and everything. He was just calling to see would it be alright for him to take that second shot on 11Feb2021 if it was shingles. The outcome of the event was unknown.   Information about the Lot/batch number has been requested.
11/28/07[11:30AM] Sinus pressure/headache/aching throat within 1-hour of vaccine. Following morning 11/29/07 [6:30AM] severe sinus pressure, swollen face, throat pressure. [2:30PM] significant facial pain, symptoms of throat closing. [3:15PM] Dr. Visit to MD primary care physician - confirmed sinus infection and breathing difficulty; prescribed Arithromycin and Benedryl. Took 2 benedryl every 4 hours for remainder of day; took 2 Arithromycin. 11/30/07 [6:30AM] continued taking Benedryl every 4 hours for throat pressure; taking one Arithromycin for add'l 4 days.
My COVID-19 symptoms started on 12/15/2022 in the morning around 08:00 I had a sore throat and cough. On 12/16/2022 I had headache, body aches, sore throat, fatigue, and cough. I did a home test on 12/16/2022  in the morning which was positive. In the early evening on the day I tested positive I went to the Urgent Care. They prescribed me with Paxlovid for 5 days.  I still have cough and fatigue.  I am recovering from my COVID-19 infection.
Passed out; This is a spontaneous report received from contactable consumer. The reporter is the patient.  A 81 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 18Mar2021 10:10 (Lot number: ER2613) at the age of 81 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "allergies toward caffeine" (unspecified if ongoing); "shellfish allergy" (unspecified if ongoing); "sore knee" (unspecified if ongoing); "injection in her eye" (unspecified if ongoing). Concomitant medication(s) included: SUPARTZ taken for arthralgia, start date: 15Feb2021, stop date: 15Feb2021; EYLEA taken for eye disorder. Past drug history included: Codeine, reaction(s): "allergies"; Eylea. Vaccination history included: Bnt162b2 (dose 1 (lot number: EN6202), in the upper left arm), administration date: 25Feb2021, when the patient was 81 years old, for COVID-19 immunization. The following information was reported: LOSS OF CONSCIOUSNESS (medically significant) with onset 18Mar2021, outcome "recovered", described as "Passed out". The patient underwent the following laboratory tests and procedures: computerised tomogram: clear. The patient was wondering abut the booster shot. She states she had a problem with the original second shot she received. She states with the second shot received on 19Mar2021, she passed out that evening. She received her second shot two weeks after the first one, but it's more involved than that. On 15Feb2021, she had an injection for a sore knee. She clarifies the name of the drug is Supartz FX and it was a series of 4 injections. She had one injection before the 2 shots and then after the two shots, she had two more. After the Supartz FX, she had an injection in her eye called Eylea. The caller clarifies she has no NDC, Lot or expiry date for the Supartz FX or the Eylea. So, she had a series of shots in a very short time. The patient clarified that the day she passed out was 18Mar2021 and she wanted to report that. Also, she wanted to know how safe it is to get the booster shot. Her doctor recommended her getting the moderna shot because it wasn't strong as Pfizer but according to all of the information that has come out, it says to stick to the same drug. The patient wanted to know how safe it is for her to get the booster shot. She is inclined to skip it because she is afraid of Pfizer but as she stated earlier, her doctor suggested she get the Moderna. However, according to the research that has come out, it says to not to mix the shots, so she is confused by that. The caller clarifies it took about 24 hours for her to recover from passing out. However, she did not go to the doctor or emergency room.   Follow-up attempts are completed. No further information is expected.
Extreme rash on face and neck. Pimple-like appearance. Redness, tingling, burning and itching
Reaction to ZOSTAVAX - at injection site - red, raised silver dollar sized. Not sore, but itching.
patient felt weak after shot and sat down. was pale and on walking back to exam room, slumped to floor (gently lowered by staff). awake and interactive upon lying down. recovered completely after 30 minutes. had diaphoresis. no diff breathing. had not eating for 9 hours before shot. able to eat and drink. vitals stable. event c/w vasovagal episode
Subclavicular lymph node is swollen and tender. The injection was placed high up near the top of the deltoid muscle. The site bleed abnormally  immediately after the needle was withdrawn. The injection itself was unusually uncomfortable.